This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
ACUTE GVHD TRIGGERED BY COVID-19 IN A BONE MARROW RECIPIENT (preprint)
authorea preprints; 2022.
Preprint
in English
| PREPRINT-AUTHOREA PREPRINTS | ID: ppzbmed-10.22541.au.164864637.74673917.v1
ABSTRACT
Introduction:
There are few reports regarding risk of COVID-19-associated complications in bone marrow recipients. We report a patient who had graft-versus-host disease triggered by COVID-19. Results The patient was a 17-year-old boy who underwent HSCT from matched sibling donor for CML. He had complete donor chimerism at day +30. Cyclosporine was tapered and stopped at day +65. Until day +93, he had no complaints. The patient started to suffer from cutaneus and gastro-intestinal grade III GVHD after the diagnossis of CIVID-19. Discussion In the absence of any other condition to explain this clinical picture and the good response to GVHD treatment indicate that the triggering factor in the development of GVHD may be COVID-19 in the era of TLR, which plays a common role in the pathogenesis of both GVHD and COVID-19.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-AUTHOREA PREPRINTS
Language:
English
Year:
2022
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS